Medidata Solutions Inc  

(Public, NASDAQ:MDSO)   Watch this stock  
Find more results for David Wilhite�
44.84
-2.09 (-4.45%)
After Hours: 44.84 0.00 (0.00%)
Jul 31, 5:04PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 44.78 - 47.04
52 week 32.10 - 68.21
Open 46.19
Vol / Avg. 649,037.00/656,194.00
Mkt cap 2.43B
P/E 265.83
Div/yield     -
EPS 0.17
Shares 54.10M
Beta 0.69
Inst. own 97%
Oct 22, 2014
Q3 2014 Medidata Solutions Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Aug 5, 2014
Medidata Solutions Inc at Needham Interconnect Conference - 2:00PM EDT - Add to calendar
Jul 29, 2014
Q2 2014 MEDIDATA SOLUTIONS INC Earnings Release
Jul 29, 2014
Q2 2014 Medidata Solutions Inc Earnings Call - Webcast
May 28, 2014
MEDIDATA SOLUTIONS INC Annual Shareholder Meeting (Virtual)
May 19, 2014
MEDIDATA SOLUTIONS INC at JPMorgan Global Technology, Media and Telecom Conference
May 7, 2014
MEDIDATA SOLUTIONS INC at Jefferies Global Technology, Media & Telecom Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -2.37% 6.02%
Operating margin 0.36% 8.63%
EBITD margin - 11.13%
Return on average assets -1.28% 4.18%
Return on average equity -3.23% 9.06%
Employees 923 -
CDP Score - -

Address

8th Floor, 79 Fifth Avenue
NEW YORK, NY 10003
United States - Map
+1-212-9181800 (Phone)
+1-212-9181818 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Medidata Solutions, Inc. (Medidata) is a global provider of software-as-a-service (SaaS), clinical technology solutions. Medidata offers Medidata Rave, is a platform that integrates electronic data capture (EDC), with a clinical data management system (CDMS), in a solution that replaces traditional paper-based methods of capturing and managing clinical data. Medidata Rave offers a platform enabling sponsors to manage complex trials. Medidata customers are pharmaceutical, biotechnology and medical device companies, academic institutions, contract research organizations (CROs), and other organizations engaged in clinical trials to bring medical products and treatments to market and explore indications for existing medical products. Medidata Rave�s intuitive, user-friendly Internet-based technology facilitates rapid adoption by investigators, sponsors and CROs. On July 1, 2011, the Company acquired Clinical Force Limited (Clinical Force).

Officers and directors

Tarek A. Sherif Chairman of the Board, Chief Executive Officer
Age: 51
Bio & Compensation  - Reuters
Glen M. de Vries President, Director
Age: 41
Bio & Compensation  - Reuters
Cory A. Douglas Chief Financial Officer, Executive Vice President
Age: 43
Bio & Compensation  - Reuters
Steven F. Wilhite Executive Vice President, Chief Marketing Officer
Age: 61
Bio & Compensation  - Reuters
Michael I. Otner Executive Vice President, General Counsel, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Eileen M. Schloss Executive Vice President - Human Resources
Age: 60
Bio & Compensation  - Reuters
Steven I. Hirschfeld Executive Vice President - Chief Value Officer
Age: 51
Bio & Compensation  - Reuters
Alan V. Mateo Executive vice president - field operations
Age: 51
Bio & Compensation  - Reuters
Bryan C. Spielman Executive Vice President - Strategy and Corporate Development
Age: 47
Bio & Compensation  - Reuters
David Colistra Senior Vice President, Chief Accounting Officer
Bio & Compensation  - Reuters